Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

IL-15 and IFN-γ signal through the ERK pathway to inhibit HCV replication, independent of type I IFN signaling.

Vahedi F, Lee AJ, Collins SE, Chew MV, Lusty E, Chen B, Dubey A, Richards CD, Feld JJ, Russell RS, Mossman KL, Ashkar AA.

Cytokine. 2018 Jun 13. pii: S1043-4666(18)30254-0. doi: 10.1016/j.cyto.2018.06.006. [Epub ahead of print]

PMID:
29908921
2.

Monocytes activate natural killer cells via inflammasome-induced interleukin 18 in response to hepatitis C virus replication.

Serti E, Werner JM, Chattergoon M, Cox AL, Lohmann V, Rehermann B.

Gastroenterology. 2014 Jul;147(1):209-220.e3. doi: 10.1053/j.gastro.2014.03.046. Epub 2014 Mar 28.

3.

IFN-γ production by human natural killer cells in response to HCV-infected hepatoma cells is dependent on accessory cells.

Zhang S, Saha B, Kodys K, Szabo G.

J Hepatol. 2013 Sep;59(3):442-9. doi: 10.1016/j.jhep.2013.04.022. Epub 2013 May 7.

4.

Involvement of ERK pathway in interferon alpha-mediated antiviral activity against hepatitis C virus.

Zhao LJ, Wang W, Wang WB, Ren H, Qi ZT.

Cytokine. 2015 Mar;72(1):17-24. doi: 10.1016/j.cyto.2014.11.031. Epub 2014 Dec 23.

PMID:
25544181
5.

Interferon-gamma: biologic functions and HCV terapy (type I/II) (2 of 2 parts).

Gattoni A, Parlato A, Vangieri B, Bresciani M, Derna R.

Clin Ter. 2006 Sep-Oct;157(5):457-68. Review. Retraction in: Clin Ter. 2008 May-Jun;159(3):208.

PMID:
17147054
6.

Human type 2 myeloid dendritic cells produce interferon-λ and amplify interferon-α in response to hepatitis C virus infection.

Zhang S, Kodys K, Li K, Szabo G.

Gastroenterology. 2013 Feb;144(2):414-425.e7. doi: 10.1053/j.gastro.2012.10.034. Epub 2012 Oct 23.

7.

An effective interferon-gamma-mediated inhibition of hepatitis C virus replication by natural killer cells is associated with spontaneous clearance of acute hepatitis C in human immunodeficiency virus-positive patients.

Kokordelis P, Krämer B, Körner C, Boesecke C, Voigt E, Ingiliz P, Glässner A, Eisenhardt M, Wolter F, Kaczmarek D, Nischalke HD, Rockstroh JK, Spengler U, Nattermann J.

Hepatology. 2014 Mar;59(3):814-27. doi: 10.1002/hep.26782. Epub 2014 Jan 21.

PMID:
24382664
8.

Natural killer cells inhibit hepatitis C virus expression.

Li Y, Zhang T, Ho C, Orange JS, Douglas SD, Ho WZ.

J Leukoc Biol. 2004 Dec;76(6):1171-9. Epub 2004 Aug 31.

PMID:
15339939
9.

Colocalization of the IL-12 receptor and FcgammaRIIIa to natural killer cell lipid rafts leads to activation of ERK and enhanced production of interferon-gamma.

Kondadasula SV, Roda JM, Parihar R, Yu J, Lehman A, Caligiuri MA, Tridandapani S, Burry RW, Carson WE 3rd.

Blood. 2008 Apr 15;111(8):4173-83. doi: 10.1182/blood-2007-01-068908. Epub 2008 Jan 3.

10.

Effect of ethanol on innate antiviral pathways and HCV replication in human liver cells.

Plumlee CR, Lazaro CA, Fausto N, Polyak SJ.

Virol J. 2005 Dec 2;2:89.

11.

Interferon α-stimulated natural killer cells from patients with acute hepatitis C virus (HCV) infection recognize HCV-infected and uninfected hepatoma cells via DNAX accessory molecule-1.

Stegmann KA, Björkström NK, Ciesek S, Lunemann S, Jaroszewicz J, Wiegand J, Malinski P, Dustin LB, Rice CM, Manns MP, Pietschmann T, Cornberg M, Ljunggren HG, Wedemeyer H.

J Infect Dis. 2012 May 1;205(9):1351-62. doi: 10.1093/infdis/jis210. Epub 2012 Mar 29.

12.

HIV mono-infection is associated with an impaired anti-hepatitis C virus activity of natural killer cells.

Goeser F, Glässner A, Kokordelis P, Wolter F, Lutz P, Kaczmarek DJ, Schwarze-Zander C, Boesecke C, Strassburg CP, Rockstroh JK, Spengler U, Krämer B, Nattermann J.

AIDS. 2016 Jan 28;30(3):355-63. doi: 10.1097/QAD.0000000000000963.

PMID:
26558728
13.

Downregulation of interleukin-18-mediated cell signaling and interferon gamma expression by the hepatitis B virus e antigen.

Jegaskanda S, Ahn SH, Skinner N, Thompson AJ, Ngyuen T, Holmes J, De Rose R, Navis M, Winnall WR, Kramski M, Bernardi G, Bayliss J, Colledge D, Sozzi V, Visvanathan K, Locarnini SA, Kent SJ, Revill PA.

J Virol. 2014 Sep;88(18):10412-20. doi: 10.1128/JVI.00111-14. Epub 2014 May 28.

14.

Antiviral action of interferon-alpha against hepatitis C virus replicon and its modulation by interferon-gamma and interleukin-8.

Jia Y, Wei L, Jiang D, Wang J, Cong X, Fei R.

J Gastroenterol Hepatol. 2007 Aug;22(8):1278-85. Epub 2007 Jun 12.

PMID:
17565587
15.

DDX60L Is an Interferon-Stimulated Gene Product Restricting Hepatitis C Virus Replication in Cell Culture.

Grünvogel O, Esser-Nobis K, Reustle A, Schult P, Müller B, Metz P, Trippler M, Windisch MP, Frese M, Binder M, Fackler O, Bartenschlager R, Ruggieri A, Lohmann V.

J Virol. 2015 Oct;89(20):10548-68. doi: 10.1128/JVI.01297-15. Epub 2015 Aug 12.

16.

Hepatitis C virus replication in mouse cells is restricted by IFN-dependent and -independent mechanisms.

Nandakumar R, Finsterbusch K, Lipps C, Neumann B, Grashoff M, Nair S, Hochnadel I, Lienenklaus S, Wappler I, Steinmann E, Hauser H, Pietschmann T, Kröger A.

Gastroenterology. 2013 Dec;145(6):1414-23.e1. doi: 10.1053/j.gastro.2013.08.037. Epub 2013 Aug 21.

PMID:
23973921
17.

GP73 represses host innate immune response to promote virus replication by facilitating MAVS and TRAF6 degradation.

Zhang X, Zhu C, Wang T, Jiang H, Ren Y, Zhang Q, Wu K, Liu F, Liu Y, Wu J.

PLoS Pathog. 2017 Apr 10;13(4):e1006321. doi: 10.1371/journal.ppat.1006321. eCollection 2017 Apr. Erratum in: PLoS Pathog. 2018 Mar 13;14 (3):e1006938.

18.

Identification of type I and type II interferon-induced effectors controlling hepatitis C virus replication.

Metz P, Dazert E, Ruggieri A, Mazur J, Kaderali L, Kaul A, Zeuge U, Windisch MP, Trippler M, Lohmann V, Binder M, Frese M, Bartenschlager R.

Hepatology. 2012 Dec;56(6):2082-93. doi: 10.1002/hep.25908. Epub 2012 Oct 14.

PMID:
22711689
19.

Interferon-gamma: biologic functions and HCV therapy (type I/II) (1 of 2 parts).

Gattoni A, Parlato A, Vangieri B, Bresciani M, Derna R.

Clin Ter. 2006 Jul-Aug;157(4):377-86. Review. Retraction in: Clin Ter. 2008 May-Jun;159(3):207.

PMID:
17051976
20.

Supplemental Content

Support Center